View:
United States securities and exchange commission logo
September 1, 2020
David L. Lucchino
President and Chief Executive Officer
Frequency Therapeutics, Inc.
19 Presidential Way, 2nd Floor
Woburn, MA 01801
Re: Frequency
Therapeutics, Inc.
Registration
Statement on Form S-1
Filed August 28,
2020
File No. 333-248474
Dear Mr. Lucchino:
This is to advise you that we have not reviewed and will not
review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
Please contact Tim
Buchmiller at (202) 551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: John Chory, Esq.